GANGLIONEUROBLASTOMA
Clinical trials for GANGLIONEUROBLASTOMA explained in plain language.
Never miss a new study
Get alerted when new GANGLIONEUROBLASTOMA trials appear
Sign up with your email to follow new studies for GANGLIONEUROBLASTOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New immunotherapy combo shows promise for tough childhood cancer
Disease control CompletedThis study tested whether adding two immunotherapy drugs (dinutuximab and GM-CSF) to standard chemotherapy is safe and doable for children newly diagnosed with high-risk neuroblastoma. Forty-two children took part. The goal was to see if the extra drugs cause too many side effect…
Matched conditions: GANGLIONEUROBLASTOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New combo therapy shows promise for tough childhood cancer
Disease control CompletedThis study tested a very strong treatment plan for children newly diagnosed with high-risk neuroblastoma, a serious nerve cell cancer. The approach combined intensive chemotherapy, a radioactive drug called 131I-MIBG, and a stem cell transplant to try to kill more cancer cells. T…
Matched conditions: GANGLIONEUROBLASTOMA
Phase: PHASE1 • Sponsor: Children's Oncology Group • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC